SCHIFFMANN; Raphael

Patent Applications and Registrations

Patent applications and USPTO patent grants for SCHIFFMANN; Raphael.The latest application filed is for "triheptanoin for the treatment of glucose transport 1 deficiency".

Company Profile

1.9.10

SCHIFFMANN; Raphael - Rockwall TX
Schiffmann; Raphael - Rockwell TX US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Triheptanoin For The Treatment Of Glucose Transport 1 Deficiency App 20190290610 - MOCHEL; Fanny ; et al.	2019-09-26
Triheptanoin for the treatment of glucose transport 1 deficiency Grant 10,111,848 - Mochel , et al. October 30, 2	2018-10-30
Urinary triaosylceramide (Gb3) as a marker of cardiac disease Grant 9,750,732 - Schiffmann , et al. September 5, 2	2017-09-05
Triheptanoin For The Treatment Of Glucose Transport 1 Deficiency App 20160374980 - Mochel; Fanny ; et al.	2016-12-29
Triheptanoin for the treatment of glucose transport 1 deficiency Grant 9,468,229 - Mochel , et al. October 18, 2	2016-10-18
Urinary Triaosylceramide (GB3) as a Marker of Cardiac Disease App 20150342939 - Schiffmann; Raphael ; et al.	2015-12-03
Establishment of patient- or person-specific cardiac myocyte cell lines from human induced pluripotent stem cells (iPSCs) Grant 9,155,765 - Meng , et al. October 13, 2	2015-10-13
Urinary triaosylceramide (GB3) as a marker of cardiac disease Grant 9,066,939 - Schiffmann , et al. June 30, 2	2015-06-30
Triheptanoin For The Treatment Of Glucose Transport 1 Deficiency App 20140221482 - Mochel; Fanny ; et al.	2014-08-07
Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease Grant 8,410,101 - Schiffmann , et al. April 2, 2	2013-04-02
ESTABLISHMENT OF PATIENT- OR PERSON- SPECIFIC CARDIAC MYOCYTE CELL LINES FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (iPSCs) App 20130011371 - Meng; Xingli ; et al.	2013-01-10
Triheptanoin Diet For Adult Polyglucosan Body Disease (apbd) Treatment App 20110306663 - Schiffmann; Raphael ; et al.	2011-12-15
Involvement of Androgen/Androgen Receptor Pathway in Fabry Disease App 20110217288 - Shen; Jinsong ; et al.	2011-09-08
Urinary Triaosylceramide (GB3) as a Marker of Cardiac Disease App 20110172271 - Schiffmann; Raphael ; et al.	2011-07-14
Treatment of Male-Pattern Baldness by Local Induction of the Metabolic Defect of Fabry Disease App 20110112041 - Schiffmann; Raphael	2011-05-12
Use of Tetrahydrobiopterin as a Marker and a Therapeutic Agent for Fabry Disease App 20100260747 - Schiffmann; Raphael ; et al.	2010-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.